02/19/2021 4:14 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting) BIOTECHNOLOGY VALUE FUND L P (Reporting) Biotechnology Value Trading Fund OS LP (Reporting) BVF GP HOLDINGS LLC (Reporting) BVF I GP LLC (Reporting) BVF II GP LLC (Reporting) BVF INC/IL (Reporting) BVF PARTNERS L P/IL (Reporting) BVF Partners OS Ltd. (Reporting) Infinity Pharmaceuticals (Issuer) LAMPERT MARK N (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/19/2021 4:10 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Infinity Pharmaceuticals (Subject)
| Form SC 13G
| |
02/12/2021 3:44 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/11/2021 8:55 PM | Infinity Pharmaceuticals (Filer)
| Form S-3MEF
| |
02/11/2021 6:16 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/26/2021 4:27 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting) BIOTECHNOLOGY VALUE FUND L P (Reporting) Biotechnology Value Trading Fund OS LP (Reporting) BVF GP HOLDINGS LLC (Reporting) BVF I GP LLC (Reporting) BVF II GP LLC (Reporting) BVF INC/IL (Reporting) BVF PARTNERS L P/IL (Reporting) BVF Partners OS Ltd. (Reporting) Infinity Pharmaceuticals (Issuer) LAMPERT MARK N (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/26/2021 4:26 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Infinity Pharmaceuticals (Subject)
| Form SC 13D/A
| |
01/26/2021 11:21 AM | EcoR1 Capital, LLC (Filed by) Infinity Pharmaceuticals (Subject)
| Form SC 13G
| |
01/06/2021 8:17 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/23/2020 3:05 PM | Infinity Pharmaceuticals (Issuer) Tasker Seth A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
12/09/2020 8:13 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/12/2020 4:13 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Infinity Pharmaceuticals (Subject)
| Form SC 13D/A
| |
11/09/2020 3:16 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/29/2020 6:41 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/18/2020 5:48 PM | Infinity Pharmaceuticals (Subject) Opaleye Management Inc. (Filed by)
| Form SC 13G
| |
08/25/2020 7:05 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/30/2020 6:04 PM | Infinity Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/30/2020 6:03 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/26/2020 9:43 AM | Infinity Pharmaceuticals (Filer)
| Form CT ORDER
| |
06/18/2020 3:22 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/18/2020 7:34 AM | Infinity Pharmaceuticals (Issuer) VENUTI MICHAEL C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2020 7:33 AM | Infinity Pharmaceuticals (Issuer) SELBY NORMAN C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2020 7:30 AM | BEIER DAVID W (Reporting) Infinity Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2020 7:30 AM | Agresta Samuel (Reporting) Infinity Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2020 7:30 AM | EVNIN ANTHONY B (Reporting) Infinity Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2020 7:40 AM | Infinity Pharmaceuticals (Filer)
| Form DEFA14A
| |
05/11/2020 6:37 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/11/2020 6:24 AM | Infinity Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/27/2020 7:30 AM | Infinity Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/07/2020 6:47 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2020 6:48 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/17/2020 7:00 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/19/2020 8:58 AM | Infinity Pharmaceuticals (Filer)
| Form CT ORDER
| |
01/13/2020 4:01 PM | Infinity Pharmaceuticals (Issuer) Tasker Seth A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2020 4:01 PM | BLOCH LAWRENCE E (Reporting) Infinity Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2020 4:01 PM | Infinity Pharmaceuticals (Issuer) Kutok Jeffery (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2020 4:00 PM | Infinity Pharmaceuticals (Issuer) Perkins Adelene Q (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2020 7:00 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2020 4:22 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Infinity Pharmaceuticals (Subject)
| Form SC 13D/A
| |
01/09/2020 6:43 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2019 2:13 PM | Infinity Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/16/2019 6:18 PM | Agresta Samuel (Reporting) Infinity Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2019 6:14 PM | Agresta Samuel (Reporting) Infinity Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/22/2019 3:05 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/30/2019 7:32 AM | Infinity Pharmaceuticals (Filer)
| Form 424B5
| |
07/30/2019 6:44 AM | Infinity Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/30/2019 6:35 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2019 3:26 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2019 3:06 PM | EVNIN ANTHONY B (Reporting) Infinity Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2019 3:06 PM | Infinity Pharmaceuticals (Issuer) SELBY NORMAN C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2019 3:06 PM | BEIER DAVID W (Reporting) Infinity Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2019 3:05 PM | Infinity Pharmaceuticals (Issuer) VENUTI MICHAEL C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2019 3:05 PM | BLOCH LAWRENCE E (Reporting) Infinity Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2019 3:05 PM | Infinity Pharmaceuticals (Issuer) Kauffman Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2019 3:05 PM | Infinity Pharmaceuticals (Issuer) Perkins Adelene Q (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2019 3:05 PM | Berkowitz Jeffrey (Reporting) Infinity Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2019 6:32 AM | Infinity Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/13/2019 3:56 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2019 3:11 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2019 2:16 PM | Infinity Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2019 11:15 PM | Infinity Pharmaceuticals (Filer)
| Form EFFECT
| |
04/24/2019 7:30 AM | Infinity Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/08/2019 4:03 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/14/2019 9:10 AM | Infinity Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/14/2019 6:38 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/14/2019 6:06 AM | Infinity Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/06/2019 6:53 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/28/2019 7:00 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/07/2019 3:07 PM | Infinity Pharmaceuticals (Issuer) Tasker Seth A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2019 3:06 PM | BLOCH LAWRENCE E (Reporting) Infinity Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2019 3:05 PM | Infinity Pharmaceuticals (Issuer) Kutok Jeffery (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2019 3:05 PM | Agresta Samuel (Reporting) Infinity Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2019 3:05 PM | Infinity Pharmaceuticals (Issuer) Perkins Adelene Q (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2019 6:46 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/17/2018 6:40 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting) BIOTECHNOLOGY VALUE FUND L P (Reporting) Biotechnology Value Trading Fund OS LP (Reporting) BVF INC/IL (Reporting) BVF PARTNERS L P/IL (Reporting) BVF Partners OS Ltd. (Reporting) Infinity Pharmaceuticals (Issuer) LAMPERT MARK N (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2018 5:28 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting) BIOTECHNOLOGY VALUE FUND L P (Reporting) Biotechnology Value Trading Fund OS LP (Reporting) BVF INC/IL (Reporting) BVF PARTNERS L P/IL (Reporting) BVF Partners OS Ltd. (Reporting) Infinity Pharmaceuticals (Issuer) LAMPERT MARK N (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2018 4:57 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting) BIOTECHNOLOGY VALUE FUND L P (Reporting) Biotechnology Value Trading Fund OS LP (Reporting) BVF INC/IL (Reporting) BVF PARTNERS L P/IL (Reporting) BVF Partners OS Ltd. (Reporting) Infinity Pharmaceuticals (Issuer) LAMPERT MARK N (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2018 4:24 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Infinity Pharmaceuticals (Subject)
| Form SC 13D/A
| |
11/15/2018 7:07 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting) BIOTECHNOLOGY VALUE FUND L P (Reporting) Biotechnology Value Trading Fund OS LP (Reporting) BVF INC/IL (Reporting) BVF PARTNERS L P/IL (Reporting) BVF Partners OS Ltd. (Reporting) Infinity Pharmaceuticals (Issuer) LAMPERT MARK N (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/05/2018 2:33 PM | Infinity Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
09/30/2018 11:00 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2018 4:10 PM | Agresta Samuel (Reporting) Infinity Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2018 4:05 PM | Agresta Samuel (Reporting) Infinity Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/07/2018 3:13 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2018 2:27 PM | Infinity Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/26/2018 10:52 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2018 4:00 PM | Infinity Pharmaceuticals (Issuer) Kutok Jeffery (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2018 5:57 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting) BIOTECHNOLOGY VALUE FUND L P (Reporting) Biotechnology Value Trading Fund OS LP (Reporting) BVF INC/IL (Reporting) BVF PARTNERS L P/IL (Reporting) BVF Partners OS Ltd. (Reporting) Infinity Pharmaceuticals (Issuer) LAMPERT MARK N (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2018 4:23 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Infinity Pharmaceuticals (Subject)
| Form SC 13D/A
| |
06/14/2018 7:37 AM | Infinity Pharmaceuticals (Issuer) SELBY NORMAN C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2018 7:35 AM | Berkowitz Jeffrey (Reporting) Infinity Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2018 7:34 AM | Infinity Pharmaceuticals (Issuer) SMITH IAN F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2018 7:33 AM | EVNIN ANTHONY B (Reporting) Infinity Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2018 7:32 AM | Infinity Pharmaceuticals (Issuer) Kauffman Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2018 7:31 AM | Infinity Pharmaceuticals (Issuer) VENUTI MICHAEL C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2018 7:30 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2018 7:30 AM | BEIER DAVID W (Reporting) Infinity Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2018 11:15 PM | Infinity Pharmaceuticals (Filer)
| Form EFFECT
| |
05/08/2018 3:12 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2018 2:36 PM | Infinity Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |